DIMA BIOTECH
Dima Biotech is a tumor immunotherapy and monoclonal antibody developer, specializing in the development of recombinant monoclonal antibodies for tumor immune products and services. It has the unique RECmAb digital monoclonal antibody technology, which can be used to obtain a variety of genus and high quality. Monoclonal antibodies.
DIMA BIOTECH
Industry:
Biotechnology Health Care
Founded:
2019-01-01
Address:
Suzhou, Jiangsu, China
Country:
China
Total Employee:
11+
Status:
Active
Total Funding:
0
Investors List
ETP Ventures
ETP Ventures investment in Angel Round - Dima Biotech
Huatai Zijin Investment
Huatai Zijin Investment investment in Angel Round - Dima Biotech
Guoqian Venture Capital
Guoqian Venture Capital investment in Angel Round - Dima Biotech
More informations about "Dima Biotech"
Dima Biotechnology - LinkedIn
DIMA Biotechnology Ltd. is a leading biotech firm specializing in preclinical R&D solutions for the Biopharma industry. We offer 5,000+ pre-designed validated antibody molecules tailored to ...See details»
Dima Biotech - Crunchbase Company Profile & Funding
Dima Biotech is a tumor immunotherapy and monoclonal antibody developer, specializing in the development of recombinant monoclonal antibodies for tumor immune products and services.See details»
Rabbit mAb Service - DIMA Biotechnology
Our team has decades of experience on high quality monoclonal antibody development services. DIMA’s monoclonal antibody (mAb) development platform is a revolutionary technology …See details»
DIMA BIOTECH Membrane Monoclonal Protei
Products for Drug Target Research DIMA Biotech has developed many on-shelf high-quality bioreagents including ECD membrane proteins, Full length membrane proteins, DimAb …See details»
Company Introduction - DIMA Biotechnology
DIMA Biotechnology LLC. is a top biotech company specializing in preclinical research and development solutions for the Biopharma industry. We offer a wide range of pre-designed and …See details»
DIMA Biotech - Sobekbio
DIMA Biotechnology Ltd. is a biotech company focusing on preclinical R&D products and services for druggable targets. They plan to complete the preparation of lead antibody molecules for all …See details»
DIMA Biotech | Science Company | Labroots
DIMA Biotechnology Ltd. is a top biotech company specializing in preclinical research and development solutions for the Biopharma industry. We offer a wide range of pre-designed and …See details»
Dima Biotechnology (Wuhan) Ltd. - Drug pipelines, Patents, …
Jan 26, 2025 Explore Dima Biotechnology (Wuhan) Ltd. with its drug pipeline, therapeutic area, technology platform, 1 literature.See details»
DIMA Biotechnology - Lead antibody molecules Switzerland
DIMA Biotechnology LLC. is a top biotech company specializing in preclinical research and development solutions for the Biopharma industry. They offer a wide range of pre-designed …See details»
DIMA Biotechnology Ltd - 2BScientific
DIMA Biotechnology LTD is a research and development company of recombinant monoclonal antibody focusing on immune oncology products and services. DIMA’s proprietary B cell …See details»
DIMA Biotechnology - Nordic Biosite
DIMA Biotechnology LLC. is a top biotech company specializing in preclinical research and development solutions for the Biopharma industry. They offer a wide range of pre-designed …See details»
DIMA Biotechnology Ltd. Contact Information | Biocompare.com
DIMA Biotechnology LTD is a biotechnology company specializing in membrane protein production and monoclonal antibody development. All our products are developed using our …See details»
Dima Main Page - DIMA Biotechnology
DIMA biotech has generated hundreds of the target specific B cell seed libraries and rabbit monoclonal antibodies (mAbs) against various druggable targets.See details»
Suzhou Dima Biotechnology Co., Ltd. - synapse.zhihuiya.com
了解Suzhou Dima Biotechnology Co., Ltd. (苏州缔码生物科技有限公司)公司的药物管线，治疗领域，技术平台，以及它的，疾病领域:肿瘤，技术平台:单克隆抗体，药物:CN114560940。See details»
DimAb Development Platform - DIMA Biotechnology
DIMA mAbs – Pioneering Monoclonal Antibody Innovation DIMA’s recombinant monoclonal antibody development platform represents a groundbreaking advancement in the realm of …See details»
Boost Your Research with DIMA’s New Conjugated Antibodies
About DIMA Biotechnology LLC DIMA Biotechnology LLC is a leading provider of innovative monoclonal antibody products and custom antibody solutions. With a strong commitment to …See details»
Establishing Canada’s first large-scale bioinnovation centre
Mar 20, 2025 A one-of-a-kind facility in Canada, the Neptune BioInnovation Centre (NBC) will encourage biotechnology advancements in areas such as smart materials, bioplastics, …See details»
Research Progress on BCMA-Targeted Therapies in Multiple …
Sep 12, 2024 3. DIMA Biotech’s Contribution to Drug Development with BCMA-Related Products DIMA Biotech is a biotechnology company specializing in preclinical research …See details»
Spatial transcriptomic imaging of an intact organism using
2 days ago This approach enables imaging without prior knowledge of the specimen’s spatial organization or genetic sequences, potentially allowing for the detection of single-nucleotide …See details»
Advances in Targeting B-Cell Maturation Antigen (BCMA) for Non …
Oct 24, 2024 DIMA Biotech offers a comprehensive range of services for early-stage antibody drug discovery, accelerating the drug development process. With a focus on over 500 drug …See details»